Streetbeat News

Products Services

ATHA

Athira Pharma announced that its Phase 2/3 LIFT-AD clinical trial for Fosgonimeton, aimed at treating mild-to-moderate Alzheimer's disease, did not meet its primary and key secondary endpoints. This could impact investor sentiment negatively.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 8:02 pm

SHPH

Shuttle Pharmaceuticals has been granted a U.S. patent for its selective histone deacetylase inhibitors, which are used to treat human diseases. This patent could enhance the company's intellectual property portfolio and potentially lead to new treatment options.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 7:47 pm

VUZI

Vuzix Corporation shares rose after Quanta Computer announced a $20 million investment in Vuzix, aimed at expanding waveguide production and developing new AR/AI smart glasses technologies.

Portfolio Pulse from Dylan Berman

September 03, 2024 | 7:44 pm

HITI

High Tide Inc. (NASDAQ:HITI) has re-launched the website for its Canadian retail brand, Canna Cabana, enhancing user experience with modern design and improved navigation. The company has seen significant growth in its Cabana Club loyalty program and discount club model. High Tide's shares were down 1.7155% at $2.005.

Portfolio Pulse from Jelena Martinovic

September 03, 2024 | 7:41 pm

GME

GameStop (NYSE:GME) shares are rising due to several recent developments. The company terminated a $250 million credit facility with Wells Fargo, is converting locations to retro gaming stores, and will release Q2 financial results on Sept. 10. Analysts expect a loss of 9 cents per share and $895.67 million in revenue. GME stock is up 11% over the past five days.

Portfolio Pulse from Erica Kollmann

September 03, 2024 | 7:39 pm

ERIC

NOK

AT&T shares are rising due to a webcast announcement featuring CEO John Stankey at an upcoming conference and a new multi-year partnership with Nokia to enhance its fiber network. Despite losing a contract to Ericsson, Nokia remains a key player in telecom infrastructure.

Portfolio Pulse from Vaishali Prayag

September 03, 2024 | 7:36 pm

AAPL

TSM

Apple shares are down as the company prepares for its annual iPhone event, where it will launch the iPhone 16 series and discontinue older models. Additionally, Apple's supply chain is impacted by Taiwan Semiconductor Manufacturing Co.'s efforts to localize neon gas production.

Portfolio Pulse from Vaishali Prayag

September 03, 2024 | 7:33 pm

C3.ai Inc (NYSE:AI) is set to report its Q1 earnings, with analysts expecting revenue of $86.9 million and a loss of 13 cents per share. The company has a history of beating EPS estimates and is diversifying into new AI sectors. Investors will watch for updates on its deal pipeline and federal agreements.

Portfolio Pulse from Chris Katje

September 03, 2024 | 7:29 pm

AMGN

AZN

BMY

JNJ

LLY

MRK

NVO

NVS

The U.S. government announced negotiated prices for ten drugs under Medicare Part D, effective January 1, 2026, aiming to save $6 billion. Despite this, U.S. drug prices remain significantly higher than in other countries. Companies like Bristol Myers Squibb, Eli Lilly, Johnson & Johnson, Merck, AstraZeneca, Novartis, Amgen, and Novo Nordisk are affected.

Portfolio Pulse from Vandana Singh

September 03, 2024 | 7:12 pm

EWJ

LMT

The U.S. State Department has approved a potential $150 million sale of follow-on technical support for Aegis Class Destroyers to Japan, as reported by Reuters citing the Pentagon.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 7:07 pm